These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20497640)

  • 1. [Efficacy of sublingual immunotherapy in children with dust mite allergic asthma].
    Ma XP; Muzhapaer D
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 May; 12(5):344-7. PubMed ID: 20497640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
    Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
    Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma.
    Ozdemir C; Yazi D; Gocmen I; Yesil O; Aydogan M; Semic-Jusufagic A; Bahceciler NN; Barlan IB
    Pediatr Allergy Immunol; 2007 Sep; 18(6):508-15. PubMed ID: 17680909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial.
    Eifan AO; Akkoc T; Yildiz A; Keles S; Ozdemir C; Bahceciler NN; Barlan IB
    Clin Exp Allergy; 2010 Jun; 40(6):922-32. PubMed ID: 20100188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study.
    Yukselen A; Kendirli SG; Yilmaz M; Altintas DU; Karakoc GB
    Int Arch Allergy Immunol; 2012; 157(3):288-98. PubMed ID: 22041501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel approach in allergen-specific immunotherapy: combination of sublingual and subcutaneous routes.
    Keles S; Karakoc-Aydiner E; Ozen A; Izgi AG; Tevetoglu A; Akkoc T; Bahceciler NN; Barlan I
    J Allergy Clin Immunol; 2011 Oct; 128(4):808-815.e7. PubMed ID: 21641635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan.
    Niu CK; Chen WY; Huang JL; Lue KH; Wang JY
    Respir Med; 2006 Aug; 100(8):1374-83. PubMed ID: 16403616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic efficacy of 3-year subcutaneous immunotherapy in asthmatic children allergic to mite].
    Li L; Hui Y; Qian J; Guo Y; Zhang XL; Zhang XJ
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 May; 15(5):368-71. PubMed ID: 23676940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind, placebo-controlled study of house dust mite immunotherapy in Chinese asthmatic patients.
    Wang H; Lin X; Hao C; Zhang C; Sun B; Zheng J; Chen P; Sheng J; Wu A; Zhong N
    Allergy; 2006 Feb; 61(2):191-7. PubMed ID: 16409195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical efficacy of subcutaneous and sublingual immunotherapy in mite-sensitized patients with allergic rhinitis].
    Zhu L; Zhu LP; Chen RX; Tao QL; Lu JH; Cheng L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Dec; 46(12):986-91. PubMed ID: 22336009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sublingual immunotherapy not effective in house dust mite-allergic children in primary care.
    de Bot CM; Moed H; Berger MY; Röder E; Hop WC; de Groot H; de Jongste JC; van Wijk RG; Bindels PJ; van der Wouden JC
    Pediatr Allergy Immunol; 2012 Mar; 23(2):150-8. PubMed ID: 22017365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study.
    Pajno GB; Caminiti L; Vita D; Barberio G; Salzano G; Lombardo F; Canonica GW; Passalacqua G
    J Allergy Clin Immunol; 2007 Jul; 120(1):164-70. PubMed ID: 17543376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of high-dose sublingual immunotherapy in children allergic to house dust mites in real-life clinical practice.
    Ferrés J; Justicia JL; García MP; Muñoz-Tudurí M; Alvà V
    Allergol Immunopathol (Madr); 2011; 39(3):122-7. PubMed ID: 20570032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study.
    Lue KH; Lin YH; Sun HL; Lu KH; Hsieh JC; Chou MC
    Pediatr Allergy Immunol; 2006 Sep; 17(6):408-15. PubMed ID: 16925685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of sublingual immunotherapy on specific antibody levels in asthmatic children allergic to house dust mites.
    Bahceciler NN; Arikan C; Taylor A; Akdis M; Blaser K; Barlan IB; Akdis CA
    Int Arch Allergy Immunol; 2005 Mar; 136(3):287-94. PubMed ID: 15722639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma--a placebo controlled study.
    Mungan D; Misirligil Z; Gürbüz L
    Ann Allergy Asthma Immunol; 1999 May; 82(5):485-90. PubMed ID: 10353581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the antiinflammatory and clinical effects of sublingual immunotherapy with carbamylated allergoid in allergic asthma with or without rhinitis. A 12-month perspective randomized, controlled, trial.
    La Grutta S; Arena A; D'Anneo WR; Gammeri E; Leonardi S; Trimarchi A; Platania D; La Rosa M
    Eur Ann Allergy Clin Immunol; 2007 Feb; 39(2):40-4. PubMed ID: 17441414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical efficacy and safety of sublingual immunotherapy using standardized Dermatophagoides farinae extract for children with combined allergic rhinitis and asthma syndrome].
    Wen CJ; Zhu MF; Ren WM; Liu XY; Qian H
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 May; 46(5):393-6. PubMed ID: 21781561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing sub-lingual immunotherapy.
    Marcucci F; Sensi L; Di Cara G; Salvatori S; Bernini M; Pecora S; Burastero SE
    Pediatr Allergy Immunol; 2005 Sep; 16(6):519-26. PubMed ID: 16176400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of sublingual immunotherapy with dermatophagoides farinae drops in patients with allergic rhinitis].
    Li TY; Chen DH; Lin ZB; Xu R
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Oct; 46(10):859-62. PubMed ID: 22321427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.